Indications:
● Maintenance treatment of asthma and prevention of bronchospasm in patients 4 years of age and older.
● Prevention of exercise-induced bronchospasm (EIB) in patients 4 years and older.
● Maintenance treatment of airflow obstruction and reducing exacerbations in patients with COPD.
Administration Guidelines:
● Serevent Diskus should be used twice daily (morning and evening) about 12 hours apart.
● The Diskus device delivers a measured dose of medication and must be used according to the instructions provided by the manufacturer.
● It should not be used as a rescue inhaler to treat sudden symptoms.
Dosage Forms:
● Serevent Diskus is a dry powder inhaler containing blister packs of the powder formulation of salmeterol xinafoate. Each actuation delivers 50 micrograms of salmeterol (as the xinafoate salt).
Safety Preclusions
Pregnancy and Breastfeeding:
● Serevent Diskus should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
● It is not known whether salmeterol is excreted in human milk; caution should be exercised when administered to nursing women.
Long-term Use:
● Patients using Serevent Diskus for chronic conditions should be regularly evaluated and monitored for appropriate therapy adjustments.
Drug Interactions:
● Beta-blockers may diminish the bronchodilatory effect of LABAs like salmeterol.
● Use caution with co-administration of other adrenergic drugs as they may potentiate the effects of salmeterol.
|
Reviews
There are no reviews yet.